Recognition of viral single-stranded RNA by Toll-like receptors.
暂无分享,去创建一个
[1] H. Gollnick,et al. Recurrence rate of superficial basal cell carcinoma following successful treatment with imiquimod 5% cream: interim 2-year results from an ongoing 5-year follow-up study in Europe. , 2005, European journal of dermatology : EJD.
[2] R. Ulevitch,et al. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. , 2000, European cytokine network.
[3] A. Krieg,et al. Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells , 2002, European journal of immunology.
[4] S. Akira,et al. Toll‐like receptor expression in murine DC subsets: lack of TLR7 expression by CD8α+ DC correlates with unresponsiveness to imidazoquinolines , 2003, European journal of immunology.
[5] P. Plotz,et al. The autoantibody repertoire: searching for order , 2003, Nature Reviews Immunology.
[6] S. Akira,et al. Murine Dendritic Cell Type I IFN Production Induced by Human IgG-RNA Immune Complexes Is IFN Regulatory Factor (IRF)5 and IRF7 Dependent and Is Required for IL-6 Production1 , 2007, The Journal of Immunology.
[7] W. Cao,et al. Integrin‐nucleated Toll‐like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling , 2002, FEBS letters.
[8] T. Kopp,et al. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells , 2007, The Journal of experimental medicine.
[9] F. Bergamin,et al. Plasmacytoid dendritic cell activation by foot‐and‐mouth disease virus requires immune complexes , 2006, European journal of immunology.
[10] A. DeFranco,et al. TLR3 and TLR7 Are Targeted to the Same Intracellular Compartments by Distinct Regulatory Elements*♦ , 2005, Journal of Biological Chemistry.
[11] D. Bernstein,et al. Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs. , 1993, The Journal of infectious diseases.
[12] M. Altfeld,et al. MyD88-Dependent Immune Activation Mediated by Human Immunodeficiency Virus Type 1-Encoded Toll-Like Receptor Ligands , 2007, Journal of Virology.
[13] P. Borrow,et al. Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon , 2003, Nature Immunology.
[14] K. Hattermann,et al. The Toll‐like receptor 7/8‐ligand resiquimod (R‐848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet‐activating factor biosynthesis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] E. Gilboa,et al. Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation 1 , 2003, The Journal of Immunology.
[16] S. Akira,et al. Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.
[17] R. Medzhitov,et al. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA , 2006, Nature Immunology.
[18] A. Judge,et al. 2'-O-methyl-modified RNAs act as TLR7 antagonists. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.
[19] M. Nolte,et al. Dendritic cell quiescence during systemic inflammation driven by LPS stimulation of radioresistant cells in vivo , 2007, The Journal of experimental medicine.
[20] C. Gardiner,et al. TLR7/8-Mediated Activation of Human NK Cells Results in Accessory Cell-Dependent IFN-γ Production1 , 2005, The Journal of Immunology.
[21] Jeffrey S. Miller,et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. , 2006, International immunology.
[22] J. Dai,et al. Comparative analysis of IRF and IFN‐alpha expression in human plasmacytoid and monocyte‐derived dendritic cells , 2003, Journal of leukocyte biology.
[23] K. Klotz,et al. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. , 2006, The Journal of investigative dermatology.
[24] R. Steinman,et al. Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.
[25] S. Akira,et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. , 2006, Blood.
[26] H. Matsue,et al. TLR3-, TLR7-, and TLR9-Mediated Production of Proinflammatory Cytokines and Chemokines from Murine Connective Tissue Type Skin-Derived Mast Cells but Not from Bone Marrow-Derived Mast Cells 1 , 2004, The Journal of Immunology.
[27] D. Tough,et al. Cutting Edge: Enhancement of Antibody Responses Through Direct Stimulation of B and T Cells by Type I IFN1 , 2006, The Journal of Immunology.
[28] G. Stingl,et al. Identification and Characterization of pDC-Like Cells in Normal Mouse Skin and Melanomas Treated with Imiquimod1 , 2004, The Journal of Immunology.
[29] R. Flavell,et al. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3 , 2001, Nature.
[30] S. Akira,et al. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. , 2007, International immunology.
[31] A. Ohta,et al. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage , 2001, Nature.
[32] S. Akira,et al. Nucleic acid agonists for Toll‐like receptor 7 are defined by the presence of uridine ribonucleotides , 2006, European journal of immunology.
[33] B. Finlay,et al. Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens , 2006, Cell.
[34] T. Wu,et al. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[36] M. Colonna,et al. Dendritic cells respond to influenza virus through TLR7‐ and PKR‐independent pathways , 2005, European journal of immunology.
[37] Dong Yu,et al. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8 , 2007, Proceedings of the National Academy of Sciences.
[38] B. Monks,et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome , 2004, Nature Immunology.
[39] C. Sousa. Activation of dendritic cells: translating innate into adaptive immunity. , 2004 .
[40] Shizuo Akira,et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses , 2004, Nature Immunology.
[41] C. Lacey,et al. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts , 2000, Sexually Transmitted Infections.
[42] Douglas T. Golenbock,et al. Flavivirus Activation of Plasmacytoid Dendritic Cells Delineates Key Elements of TLR7 Signaling beyond Endosomal Recognition1 , 2006, The Journal of Immunology.
[43] Shizuo Akira,et al. Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.
[44] Alex K. Heer,et al. TLR Signaling Fine-Tunes Anti-Influenza B Cell Responses without Regulating Effector T Cell Responses1 , 2007, The Journal of Immunology.
[45] S. Ibbotson,et al. A pilot study of treatment of lentigo maligna with 5% imiquimod cream , 2004, The British journal of dermatology.
[46] J. Battiste,et al. Oligodeoxynucleotides Differentially Modulate Activation of TLR7 and TLR8 by Imidazoquinolines , 2006, The Journal of Immunology.
[47] M. Sioud. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. , 2005, Journal of molecular biology.
[48] J. Lifson,et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. , 2005, The Journal of clinical investigation.
[49] M. Fuertes,et al. Engagement of TLR3, TLR7, and NKG2D Regulate IFN-γ Secretion but Not NKG2D-Mediated Cytotoxicity by Human NK Cells Stimulated with Suboptimal Doses of IL-121 , 2007, The Journal of Immunology.
[50] Hiroyuki Oshiumi,et al. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling. , 2004, International immunology.
[51] S. Akira,et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. , 2006, Immunity.
[52] T. Giese,et al. Plasmacytoid Dendritic Cells Control TLR7 Sensitivity of Naive B Cells via Type I IFN1 , 2005, The Journal of Immunology.
[53] S. Akira,et al. Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells , 2003, The Journal of experimental medicine.
[54] D. Walls,et al. Manipulation of the Toll-Like Receptor 7 Signaling Pathway by Epstein-Barr Virus , 2007, Journal of Virology.
[55] V. Pascual,et al. Defective B cell tolerance checkpoints in systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[56] D. Golenbock,et al. The Interferon Regulatory Factor, IRF5, Is a Central Mediator of Toll-like Receptor 7 Signaling* , 2005, Journal of Biological Chemistry.
[57] H. Hackstein,et al. TLR7 Ligands Induce Higher IFN-α Production in Females1 , 2006, The Journal of Immunology.
[58] K. Ohta,et al. Expression and Function of Toll-Like Receptors in Eosinophils: Activation by Toll-Like Receptor 7 Ligand 1 , 2003, The Journal of Immunology.
[59] H. Wagner,et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848 , 2002, Nature Immunology.
[60] S. Akira,et al. Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.
[61] S. Akira,et al. Control of coronavirus infection through plasmacytoid dendritic-cell–derived type I interferon , 2007, Blood.
[62] V. Pascual,et al. The central role of dendritic cells and interferon-&agr; in SLE , 2003 .
[63] R. Flavell,et al. Toll-like receptor 3 promotes cross-priming to virus-infected cells , 2005, Nature.
[64] A. Fauci,et al. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-α secretion in plasmacytoid dendritic cells , 2007, Proceedings of the National Academy of Sciences.
[65] A. Marshak‐Rothstein,et al. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. , 2007, Annual review of immunology.
[66] A. Iwasaki,et al. Toll-like receptor control of the adaptive immune responses , 2004, Nature Immunology.
[67] P. Henson,et al. Recognition ligands on apoptotic cells: a perspective , 2006, Journal of leukocyte biology.
[68] A. Pichlmair,et al. RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates , 2006, Science.
[69] I. Julkunen,et al. IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.
[70] D. Levy,et al. Regulation of IRF7 through cell type-specific protein stability. , 2006, Biochemical and biophysical research communications.
[71] A. DeFranco,et al. Ligand-regulated Chimeric Receptor Approach Reveals Distinctive Subcellular Localization and Signaling Properties of the Toll-like Receptors* , 2004, Journal of Biological Chemistry.
[72] T. Giese,et al. Activation with CpG-A and CpG-B Oligonucleotides Reveals Two Distinct Regulatory Pathways of Type I IFN Synthesis in Human Plasmacytoid Dendritic Cells 1 , 2003, The Journal of Immunology.
[73] B. Beutler,et al. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. , 2000, European cytokine network.
[74] John P. Vasilakos,et al. Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides , 2006, The Journal of Immunology.
[75] Houping Ni,et al. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. , 2005, Immunity.
[76] A. Satterthwaite,et al. Autoreactive B Cell Responses to RNA-Related Antigens Due to TLR7 Gene Duplication , 2006, Science.
[77] C. Samuel,et al. Antiviral Actions of Interferons , 2001, Clinical Microbiology Reviews.
[78] S. Chimenti,et al. Imiquimod Treatment of Superficial and Nodular Basal Cell Carcinoma: 12‐Week Open‐Label Trial , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[79] K. Honda,et al. Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon induction , 2005, Nature.
[80] Jongdae Lee,et al. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[81] F. Belardelli,et al. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.
[82] A. Pichlmair,et al. Innate recognition of viruses. , 2007, Immunity.
[83] K. Ishii,et al. Effect of Suppressive DNA on CpG-Induced Immune Activation1 , 2002, The Journal of Immunology.
[84] Shizuo Akira,et al. Shared and Unique Functions of the DExD/H-Box Helicases RIG-I, MDA5, and LGP2 in Antiviral Innate Immunity1 , 2005, The Journal of Immunology.
[85] S. Tyring,et al. Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study. , 2001, The Journal of infectious diseases.
[86] J. McHutchison,et al. Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies. , 2007, Journal of hepatology.
[87] S. Akira,et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus , 2005, The Journal of experimental medicine.
[88] Shizuo Akira,et al. Innate immune recognition of viral infection , 2006, Nature Immunology.
[89] L. Cekaite,et al. Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs. , 2007, Biochemical and biophysical research communications.
[90] S. Finke,et al. Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus , 2005, Journal of Virology.
[91] D. Tough,et al. Shaping of adaptive immune responses to soluble proteins by TLR agonists: A role for IFN‐α/β , 2004, Immunology and cell biology.
[92] F. Weber,et al. Activation of Innate Defense against a Paramyxovirus Is Mediated by RIG-I and TLR7 and TLR8 in a Cell-Type-Specific Manner , 2005, Journal of Virology.
[93] K. Ishii,et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses , 2006, Nature.
[94] S. Akira,et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8 , 2005, The Journal of experimental medicine.
[95] Marion Jurk,et al. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T‐rich phosphorothiate oligodeoxynucleotides , 2006, European journal of immunology.
[96] M. Gunzer,et al. incompetence due to peripheral blood leukocyte depletion Systemic administration of a TLR7 ligand leads to transient immune , 2013 .
[97] Akiko Iwasaki,et al. Recognition of single-stranded RNA viruses by Toll-like receptor 7. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[98] S. Akira,et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement , 2005, The Journal of experimental medicine.
[99] M. Altfeld,et al. Single-Stranded RNA Derived from HIV-1 Serves as a Potent Activator of NK Cells1 , 2007, The Journal of Immunology.
[100] Shohei Koyama,et al. Differential Role of TLR- and RLR-Signaling in the Immune Responses to Influenza A Virus Infection and Vaccination , 2007, The Journal of Immunology.
[101] C. Janeway. Approaching the asymptote? Evolution and revolution in immunology. , 1989, Cold Spring Harbor symposia on quantitative biology.
[102] Tak W. Mak,et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors , 2005, Nature.
[103] A. Mantovani,et al. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. , 2003, Blood.
[104] S. Akira,et al. The Toll‐like receptor 7 (TLR7)‐specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily , 2003, European journal of immunology.
[105] K. Sullivan,et al. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. , 1988, Clinical immunology and immunopathology.
[106] Helen Y Wang,et al. Tumor-Infiltrating γδ T Cells Suppress T and Dendritic Cell Function via Mechanisms Controlled by a Unique Toll-like Receptor Signaling Pathway , 2007 .
[107] M. Shlomchik,et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors , 2002, Nature.
[108] A. Iwasaki,et al. In Brief , 2007, Nature Reviews Immunology.
[109] D. Golenbock,et al. Human cardiac inflammatory responses triggered by Coxsackie B viruses are mainly Toll‐like receptor (TLR) 8‐dependent , 2005, Cellular microbiology.
[110] K. Honda,et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response , 2007, Nature.
[111] C. Schumann,et al. TLR8 and TLR7 are involved in the host's immune response to human parechovirus 1 , 2005, European journal of immunology.
[112] J. Shupe,et al. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. , 2006, Immunity.
[113] E. Kurt-Jones,et al. Cutting Edge: Antibody-Mediated TLR7-Dependent Recognition of Viral RNA1 , 2007, The Journal of Immunology.
[114] A. Yamamoto,et al. Subcellular Localization of Toll-Like Receptor 3 in Human Dendritic Cells 1 , 2003, The Journal of Immunology.
[115] Weiyi Peng,et al. Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function , 2005, Science.
[116] H. Schild,et al. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. , 2007, Blood.
[117] P. Fontoura,et al. An Immunomodulatory GpG Oligonucleotide for the Treatment of Autoimmunity via the Innate and Adaptive Immune Systems 1 , 2003, The Journal of Immunology.
[118] L. Rönnblom,et al. Role of Natural Interferon-α Producing Cells (Plasmacytoid Dendritic Cells) in Autoimmunity , 2003 .
[119] S. Akira,et al. Hepatitis C Virus Nonstructural Protein 5A Modulates the Toll-Like Receptor-MyD88-Dependent Signaling Pathway in Macrophage Cell Lines , 2007, Journal of Virology.